Pediatric antibiotic for bacterial infections; use as directed by physician.
Active Ingredient: Amoxicillin+Clavulanic Acid Pneumonia, community-acquired: Extended-release tablets only: Treatment of patients with community-acquired pneumonia (CAP) caused by confirmed or suspected beta-lactamase-producing pathogens (ie, Haemophilus influenzae, Moraxella catarrhalis, Haemophilus parainfluenzae, Klebsiella pneumoniae, methicillin-susceptible Staphylococcus aureus) and Streptococcus pneumoniae with reduced susceptibility to penicillin (penicillin minimum inhibitory concentration [MIC] = 2 mcg/mL).
Attributes
Medical Attributes
-
Active Ingredient:
Amoxicillin+Clavulanic Acid